Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti‐anginal therapy: an observational study

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-1557|24|8|803-811

ISSN: 1053-8569

Source: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.8, 2015-08, pp. : 803-811

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract